Application 020863
- Type
- NDA
- Sponsor
- OTSUKA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PLETAL | CILOSTAZOL | TABLET;ORAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | PLETAL | CILOSTAZOL | TABLET;ORAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020863-001 | PLETAL | CILOSTAZOL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-01-15 | |
| N020863-002 | PLETAL | CILOSTAZOL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-01-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N020863-001 | PLETAL | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-01-15 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N020863-002 | PLETAL | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1999-01-15 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cilostazol | CILOSTAZOL | AvKARE | dc7c2c25-36a1-e3fd-e053-2995a90adabc | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| cilostazol | CILOSTAZOL | AvPAK | aec462c8-e225-f520-cae5-80049151c0ff | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Slate Run Pharmaceuticals, LLC | db0278e9-4ece-4aaf-9216-6bcbec58206a | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| cilostazol | CILOSTAZOL | Apotex Corp. | ceac1ae3-c343-28ca-c083-b748d21a15e6 | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Chartwell RX, LLC | 77e77eaf-5556-43ac-844e-c0e29f02fe07 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| CILOSTAZOL | CILOSTAZOL | direct rx | b57d3c1e-e36f-5255-e053-2a95a90ada83 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Bryant Ranch Prepack | f728395c-684c-4087-a389-c323dbcb72dd | 2024-08-06 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| cilostazol | CILOSTAZOL | Aphena Pharma Solutions - Tennessee, LLC | 15ead884-bd4f-7f4b-e063-6394a90a8f81 | 2024-04-12 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| cilostazol | CILOSTAZOL | Aphena Pharma Solutions - Tennessee, LLC | 15478d90-312f-014e-e063-6294a90ae838 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Bryant Ranch Prepack | 53486382-eee0-4cbe-bc4a-a57484e0d5a7 | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
| Cilostazol | CILOSTAZOL | Teva Pharmaceuticals USA, Inc. | a6292311-9cb2-49ff-b8bf-12e2dbd196cd | 2022-07-31 | Boxed warning, Warnings, Adverse reactions | CILOSTAZOL |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 48454 | SUPPL | 2017-05-19 |
| 48449 | SUPPL | 2017-05-18 |
| 13637 | SUPPL | 2015-08-04 |
| 26076 | SUPPL | 2015-07-31 |
| 13636 | SUPPL | 2015-01-29 |
| 26075 | SUPPL | 2015-01-26 |
| 13635 | SUPPL | 2007-11-19 |
| 3601 | SUPPL | 2007-11-19 |
| 26074 | SUPPL | 2007-01-25 |
| 13634 | SUPPL | 2007-01-24 |
| 35526 | SUPPL | 2005-11-30 |
| 26073 | SUPPL | 2005-11-30 |
| 13633 | ORIG | 2004-06-14 |
| 3600 | SUPPL | 2004-03-03 |
| 21027 | ORIG | 1999-01-15 |
| 3599 | ORIG | 1999-01-15 |